LIFEVANTAGE CORP (LFVN) Fundamental Analysis & Valuation

NASDAQ:LFVNUS53222K2050

Current stock price

4.29 USD
-0.04 (-0.92%)
At close:
4.29 USD
0 (0%)
After Hours:

This LFVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. LFVN Profitability Analysis

1.1 Basic Checks

  • LFVN had positive earnings in the past year.
  • LFVN had a positive operating cash flow in the past year.
  • LFVN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years LFVN had a positive operating cash flow.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

  • The Return On Assets of LFVN (12.85%) is better than 89.19% of its industry peers.
  • LFVN has a better Return On Equity (23.83%) than 94.59% of its industry peers.
  • LFVN has a better Return On Invested Capital (15.68%) than 91.89% of its industry peers.
  • LFVN had an Average Return On Invested Capital over the past 3 years of 11.79%. This is in line with the industry average of 11.42%.
  • The last Return On Invested Capital (15.68%) for LFVN is above the 3 year average (11.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.85%
ROE 23.83%
ROIC 15.68%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • LFVN has a Profit Margin of 3.74%. This is in the better half of the industry: LFVN outperforms 62.16% of its industry peers.
  • In the last couple of years the Profit Margin of LFVN has declined.
  • LFVN has a Operating Margin (4.26%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of LFVN has declined.
  • LFVN has a better Gross Margin (78.75%) than 91.89% of its industry peers.
  • In the last couple of years the Gross Margin of LFVN has remained more or less at the same level.
Industry RankSector Rank
OM 4.26%
PM (TTM) 3.74%
GM 78.75%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

8

2. LFVN Health Analysis

2.1 Basic Checks

  • LFVN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, LFVN has less shares outstanding
  • The number of shares outstanding for LFVN has been reduced compared to 5 years ago.
  • LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • LFVN has an Altman-Z score of 3.11. This indicates that LFVN is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.11, LFVN is in the better half of the industry, outperforming 70.27% of the companies in the same industry.
  • LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.11
ROIC/WACC1.75
WACC8.98%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.3 Liquidity

  • LFVN has a Current Ratio of 2.03. This indicates that LFVN is financially healthy and has no problem in meeting its short term obligations.
  • LFVN has a Current ratio (2.03) which is in line with its industry peers.
  • LFVN has a Quick Ratio of 1.03. This is a normal value and indicates that LFVN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, LFVN is in line with its industry, outperforming 45.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.03
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

0

3. LFVN Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.78% over the past year.
  • The Earnings Per Share has been decreasing by -1.70% on average over the past years.
  • The Revenue has decreased by -0.99% in the past year.
  • Measured over the past years, LFVN shows a decrease in Revenue. The Revenue has been decreasing by -0.38% on average per year.
EPS 1Y (TTM)2.78%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%-31.82%
Revenue 1Y (TTM)-0.99%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%-27.79%

3.2 Future

  • Based on estimates for the next years, LFVN will show a decrease in Earnings Per Share. The EPS will decrease by -6.75% on average per year.
  • LFVN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.05% yearly.
EPS Next Y-11.95%
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%
EPS Next 5YN/A
Revenue Next Year-16.27%
Revenue Next 2Y-8.93%
Revenue Next 3Y-10.05%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

7

4. LFVN Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 5.80, the valuation of LFVN can be described as very cheap.
  • Based on the Price/Earnings ratio, LFVN is valued cheaper than 94.59% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.50, LFVN is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 6.86, the valuation of LFVN can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LFVN indicates a rather cheap valuation: LFVN is cheaper than 91.89% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of LFVN to the average of the S&P500 Index (22.67), we can say LFVN is valued rather cheaply.
Industry RankSector Rank
PE 5.8
Fwd PE 6.86
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 94.59% of the companies in the same industry are more expensive than LFVN, based on the Enterprise Value to EBITDA ratio.
  • LFVN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 32.37
EV/EBITDA 3.81
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • LFVN has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as LFVN's earnings are expected to decrease with -6.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%

5

5. LFVN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.81%, LFVN has a reasonable but not impressive dividend return.
  • The stock price of LFVN dropped by -28.67% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • LFVN's Dividend Yield is rather good when compared to the industry average which is at 1.74. LFVN pays more dividend than 86.49% of the companies in the same industry.
  • LFVN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.81%

5.2 History

  • LFVN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 28.13% of the earnings are spent on dividend by LFVN. This is a low number and sustainable payout ratio.
DP28.13%
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LFVN Fundamentals: All Metrics, Ratios and Statistics

LIFEVANTAGE CORP

NASDAQ:LFVN (3/25/2026, 4:10:11 PM)

After market: 4.29 0 (0%)

4.29

-0.04 (-0.92%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-04
Earnings (Next)05-04
Inst Owners65.99%
Inst Owner Change4.08%
Ins Owners9.2%
Ins Owner Change1.94%
Market Cap54.87M
Revenue(TTM)210.05M
Net Income(TTM)7.86M
Analysts82.5
Price Target8.16 (90.21%)
Short Float %35.16%
Short Ratio17.02
Dividend
Industry RankSector Rank
Dividend Yield 3.81%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP28.13%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-02
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.29%
Min EPS beat(2)-4.61%
Max EPS beat(2)-1.96%
EPS beat(4)1
Avg EPS beat(4)11.09%
Min EPS beat(4)-5.12%
Max EPS beat(4)56.07%
EPS beat(8)3
Avg EPS beat(8)12.28%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.32%
Min Revenue beat(2)-14.83%
Max Revenue beat(2)-11.8%
Revenue beat(4)0
Avg Revenue beat(4)-9.43%
Min Revenue beat(4)-14.83%
Max Revenue beat(4)-5.04%
Revenue beat(8)0
Avg Revenue beat(8)-7.68%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-44.83%
PT rev (3m)-44.83%
EPS NQ rev (1m)-55.87%
EPS NQ rev (3m)-59.48%
EPS NY rev (1m)-35.67%
EPS NY rev (3m)-35.67%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-24.3%
Revenue NY rev (1m)-0.68%
Revenue NY rev (3m)-15.24%
Valuation
Industry RankSector Rank
PE 5.8
Fwd PE 6.86
P/S 0.26
P/FCF 32.37
P/OCF 14.64
P/B 1.66
P/tB 1.88
EV/EBITDA 3.81
EPS(TTM)0.74
EY17.25%
EPS(NY)0.63
Fwd EY14.58%
FCF(TTM)0.13
FCFY3.09%
OCF(TTM)0.29
OCFY6.83%
SpS16.42
BVpS2.58
TBVpS2.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.55
Profitability
Industry RankSector Rank
ROA 12.85%
ROE 23.83%
ROCE 21.24%
ROIC 15.68%
ROICexc 20.67%
ROICexgc 23.45%
OM 4.26%
PM (TTM) 3.74%
GM 78.75%
FCFM 0.81%
ROA(3y)7.43%
ROA(5y)8.61%
ROE(3y)15.61%
ROE(5y)18.34%
ROIC(3y)11.79%
ROIC(5y)14.42%
ROICexc(3y)21.53%
ROICexc(5y)26%
ROICexgc(3y)21.81%
ROICexgc(5y)26.49%
ROCE(3y)15.97%
ROCE(5y)19.54%
ROICexgc growth 3Y16.93%
ROICexgc growth 5Y-18.84%
ROICexc growth 3Y17.48%
ROICexc growth 5Y-17.77%
OM growth 3Y13.18%
OM growth 5Y-4.32%
PM growth 3Y41.89%
PM growth 5Y-2.77%
GM growth 3Y-0.48%
GM growth 5Y-0.82%
F-Score7
Asset Turnover3.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 70.43%
Cap/Sales 0.98%
Interest Coverage 995.11
Cash Conversion 31.57%
Profit Quality 21.56%
Current Ratio 2.03
Quick Ratio 1.03
Altman-Z 3.11
F-Score7
WACC8.98%
ROIC/WACC1.75
Cap/Depr(3y)63.96%
Cap/Depr(5y)69.38%
Cap/Sales(3y)1.05%
Cap/Sales(5y)1.12%
Profit Quality(3y)198.8%
Profit Quality(5y)180.19%
High Growth Momentum
Growth
EPS 1Y (TTM)2.78%
EPS 3Y23.91%
EPS 5Y-1.7%
EPS Q2Q%-31.82%
EPS Next Y-11.95%
EPS Next 2Y-10.44%
EPS Next 3Y-6.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.99%
Revenue growth 3Y3.45%
Revenue growth 5Y-0.38%
Sales Q2Q%-27.79%
Revenue Next Year-16.27%
Revenue Next 2Y-8.93%
Revenue Next 3Y-10.05%
Revenue Next 5YN/A
EBIT growth 1Y-17.4%
EBIT growth 3Y17.09%
EBIT growth 5Y-4.68%
EBIT Next Year24.45%
EBIT Next 3Y-4.59%
EBIT Next 5YN/A
FCF growth 1Y-83.93%
FCF growth 3Y17.78%
FCF growth 5Y-7.66%
OCF growth 1Y-72.71%
OCF growth 3Y14.27%
OCF growth 5Y-8.31%

LIFEVANTAGE CORP / LFVN Fundamental Analysis FAQ

What is the fundamental rating for LFVN stock?

ChartMill assigns a fundamental rating of 6 / 10 to LFVN.


What is the valuation status for LFVN stock?

ChartMill assigns a valuation rating of 7 / 10 to LIFEVANTAGE CORP (LFVN). This can be considered as Undervalued.


What is the profitability of LFVN stock?

LIFEVANTAGE CORP (LFVN) has a profitability rating of 7 / 10.


What is the financial health of LIFEVANTAGE CORP (LFVN) stock?

The financial health rating of LIFEVANTAGE CORP (LFVN) is 8 / 10.


Can you provide the expected EPS growth for LFVN stock?

The Earnings per Share (EPS) of LIFEVANTAGE CORP (LFVN) is expected to decline by -11.95% in the next year.